-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On July 2, Yuandong Biological issued an announcement stating that its wholly-owned subsidiary Chengdu Youluo Biotechnology Co.
EP-9001A injection is the company's first self-developed Class 1 biological drug.
According to data from Minai.
Youluo Biotechnology has completed the pharmacological research, pharmacological and toxicological research and clinical trial design of EP-9001A injection, submitted the IND to the Food and Drug Administration and received the formal acceptance (acceptance number: CXSL2101166 country), and the proposed indications are For bone metastasis, cancer pain, no similar product has been approved for marketing at home and abroad